| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00125-009-1429-1 |
| P8608 | Fatcat ID | release_z4xqas5akjdepfoivfu5nye4va |
| P698 | PubMed publication ID | 19582394 |
| P5875 | ResearchGate publication ID | 26652155 |
| P50 | author | José Manuel García-Martínez | Q78725457 |
| P2093 | author name string | C García-Jiménez | |
| A Chocarro-Calvo | |||
| C M Moya | |||
| P2860 | cites work | TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta | Q24311416 |
| Brn-2 expression controls melanoma proliferation and is directly regulated by beta-catenin | Q24317170 | ||
| Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma | Q24336272 | ||
| A molecular mechanism for the effect of lithium on development | Q24629067 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Wnt/beta-catenin signaling in development and disease | Q27860784 | ||
| Double incretin receptor knockout (DIRKO) mice reveal an essential role for the enteroinsular axis in transducing the glucoregulatory actions of DPP-IV inhibitors | Q28258745 | ||
| Physiology of GIP--a lesson from GIP receptor knockout mice | Q28302970 | ||
| Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice | Q28510783 | ||
| Chronic desensitization of the glucose-dependent insulinotropic polypeptide receptor in diabetic rats | Q28570330 | ||
| Cell-specific expression of glucose-dependent-insulinotropic polypeptide is regulated by the transcription factor PDX-1 | Q28589086 | ||
| A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells | Q29547557 | ||
| Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure | Q30478488 | ||
| DPP IV resistance and insulin releasing activity of a novel di-substituted analogue of glucose-dependent insulinotropic polypeptide, (Ser2-Asp13)GIP. | Q30919420 | ||
| Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. | Q31855623 | ||
| TCF transcription factors: molecular switches in carcinogenesis | Q33755135 | ||
| Gastric inhibitory polypeptide: the neglected incretin revisited | Q34758871 | ||
| Wnt signaling: relevance to beta-cell biology and diabetes | Q34858330 | ||
| Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes | Q35216433 | ||
| TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program | Q35568877 | ||
| Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes | Q35916172 | ||
| Enteroendocrine precursors differentiate independently of Wnt and form serotonin expressing adenomas in response to active beta-catenin | Q36090168 | ||
| Lithium: potential therapeutics against acute brain injuries and chronic neurodegenerative diseases | Q36337317 | ||
| Lithium inhibits Smad3/4 transactivation via increased CREB activity induced by enhanced PKA and AKT signaling | Q36513464 | ||
| GATA-4 upregulates glucose-dependent insulinotropic polypeptide expression in cells of pancreatic and intestinal lineage | Q37255197 | ||
| Inhibition of gastric inhibitory polypeptide signaling prevents obesity | Q38288099 | ||
| Zebrafish prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements. | Q38520593 | ||
| Gastric inhibitory polypeptide: a gut hormone with anabolic functions | Q38666561 | ||
| Targeted ablation of glucose-dependent insulinotropic polypeptide-producing cells in transgenic mice reduces obesity and insulin resistance induced by a high fat diet | Q39599495 | ||
| Canonical Wnt signals are essential for homeostasis of the intestinal epithelium | Q39895829 | ||
| Pax6 and Pdx1 are required for production of glucose-dependent insulinotropic polypeptide in proglucagon-expressing L cells | Q39966431 | ||
| Transcriptional activation of the proglucagon gene by lithium and beta-catenin in intestinal endocrine L cells | Q40691546 | ||
| Cell-specific Expression of the Glucose-dependent Insulinotropic Polypeptide Gene in a Mouse Neuroendocrine Tumor Cell Line | Q41099776 | ||
| Clinical studies with gastric inhibitory polypeptide | Q41997201 | ||
| Development of neuroendocrine tumors in the gastrointestinal tract of transgenic mice. Heterogeneity of hormone expression | Q42055042 | ||
| Gastric Inhibitory Polypeptide (GIP) and Insulin Release in the Obese Zucker Rat | Q42455560 | ||
| Glucose dependent insulinotropic polypeptide (GIP) infused intravenously is insulinotropic in the fasting state in type 2 (non-insulin dependent) diabetes mellitus | Q42496749 | ||
| Beta-catenin can act as a nuclear import receptor for its partner transcription factor, lymphocyte enhancer factor-1 (lef-1). | Q42813950 | ||
| Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes | Q43778779 | ||
| Using TESS to predict transcription factor binding sites in DNA sequence | Q44375395 | ||
| Lithium inhibits function of voltage-dependent sodium channels and catecholamine secretion independent of glycogen synthase kinase-3 in adrenal chromaffin cells. | Q46940106 | ||
| Genetic inactivation of GIP signaling reverses aging-associated insulin resistance through body composition changes | Q46949667 | ||
| Weight change in the acute treatment of bipolar I disorder: a naturalistic observational study of psychiatric inpatients | Q47288578 | ||
| Activation of the Wnt signaling pathway: a molecular mechanism for lithium action | Q48958687 | ||
| The insulinotropic effect of GIP is impaired in patients with chronic pancreatitis and secondary diabetes mellitus as compared to patients with chronic pancreatitis and normal glucose tolerance. | Q51465919 | ||
| The glucose dependent insulinotropic polypeptide response to oral glucose and mixed meals is increased in patients with type 2 (non-insulin-dependent) diabetes mellitus. | Q51619627 | ||
| Glycogen Synthase Kinase-3 Modulates Neurite Outgrowth in Cultured Neurons: Possible Implications for Neurite Pathology in Alzheimer's Disease | Q58415675 | ||
| GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet | Q58448374 | ||
| Comparison of the enteroinsular axis in two strains of obese rat, the fatty Zucker and the JCR:LA-corpulent | Q67976335 | ||
| WNT signalling is both an inducer and effector of glucagon-like peptide-1 | Q81716066 | ||
| P433 | issue | 9 | |
| P304 | page(s) | 1913-1924 | |
| P577 | publication date | 2009-07-07 | |
| P1433 | published in | Diabetologia | Q5270140 |
| P1476 | title | WNT/beta-catenin increases the production of incretins by entero-endocrine cells | |
| P478 | volume | 52 |
| Q33811018 | Acute selective bioactivity of grape seed proanthocyanidins on enteroendocrine secretions in the gastrointestinal tract. |
| Q57402000 | Carriers of the TCF7L2 rs7903146 TT genotype have elevated levels of plasma glucose, serum proinsulin and plasma gastric inhibitory polypeptide (GIP) during a meal test |
| Q37983846 | Diet: friend or foe of enteroendocrine cells--how it interacts with enteroendocrine cells |
| Q39168828 | GLP-1(28-36) improves β-cell mass and glucose disposal in streptozotocin-induced diabetic mice and activates cAMP/PKA/β-catenin signaling in β-cells in vitro |
| Q37911549 | Glucose-dependent insulinotropic polypeptide: from pathophysiology to therapeutic opportunities in obesity-associated disorders |
| Q26752511 | Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1 |
| Q36953864 | Interaction between diet and gastrointestinal endocrine cells |
| Q26823824 | New insight into the mechanisms underlying the function of the incretin hormone glucagon-like peptide-1 in pancreatic β-cells: the involvement of the Wnt signaling pathway effector β-catenin |
| Q37763540 | The Incretins and Pancreatic beta-Cells: Use of Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide to Cure Type 2 Diabetes Mellitus |
| Q27012497 | The alliance of mesenchymal stem cells, bone, and diabetes |
| Q90561539 | The developmental Wnt signaling pathway effector β-catenin/TCF mediates hepatic functions of the sex hormone estradiol in regulating lipid metabolism |
| Q36058422 | The double trouble of metabolic diseases: the diabetes-cancer link |
| Q36309053 | The involvement of the wnt signaling pathway and TCF7L2 in diabetes mellitus: The current understanding, dispute, and perspective |
| Q36193707 | The role of the Wnt signaling pathway in incretin hormone production and function |
| Q37811421 | Wnt and Incretin Connections |
Search more.